[go: up one dir, main page]

FI89060B - Foerfarnde foer framstaellning av terapeutiskt anvaendbara peptidderivat - Google Patents

Foerfarnde foer framstaellning av terapeutiskt anvaendbara peptidderivat

Info

Publication number
FI89060B
FI89060B FI880286A FI880286A FI89060B FI 89060 B FI89060 B FI 89060B FI 880286 A FI880286 A FI 880286A FI 880286 A FI880286 A FI 880286A FI 89060 B FI89060 B FI 89060B
Authority
FI
Finland
Prior art keywords
framework
processing
therapeutic analysis
therapeutic
analysis
Prior art date
Application number
FI880286A
Other languages
English (en)
Other versions
FI880286A (fi
FI89060C (fi
FI880286A0 (fi
Inventor
John L Krstenansky
Simon J T Mao
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI880286A0 publication Critical patent/FI880286A0/fi
Publication of FI880286A publication Critical patent/FI880286A/fi
Publication of FI89060B publication Critical patent/FI89060B/fi
Application granted granted Critical
Publication of FI89060C publication Critical patent/FI89060C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
FI880286A 1987-01-23 1988-01-22 Foerfarnde foer framstaellning av terapeutiskt anvaendbara peptidderivat FI89060C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US641787A 1987-01-23 1987-01-23
US641787 1987-01-23
US5316287A 1987-05-21 1987-05-21
US5316287 1987-05-21

Publications (4)

Publication Number Publication Date
FI880286A0 FI880286A0 (fi) 1988-01-22
FI880286A FI880286A (fi) 1988-07-24
FI89060B true FI89060B (fi) 1993-04-30
FI89060C FI89060C (fi) 1993-08-10

Family

ID=26675603

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880286A FI89060C (fi) 1987-01-23 1988-01-22 Foerfarnde foer framstaellning av terapeutiskt anvaendbara peptidderivat

Country Status (19)

Country Link
EP (1) EP0276014B1 (fi)
JP (1) JP2709817B2 (fi)
KR (1) KR960014105B1 (fi)
CN (1) CN88100260A (fi)
AR (1) AR245140A1 (fi)
AT (1) ATE110743T1 (fi)
AU (1) AU601801B2 (fi)
CA (1) CA1341032C (fi)
DE (1) DE3851238T2 (fi)
DK (1) DK173757B1 (fi)
ES (1) ES2063740T3 (fi)
FI (1) FI89060C (fi)
HU (1) HU199159B (fi)
IE (1) IE63547B1 (fi)
IL (1) IL85159A (fi)
NO (1) NO174105C (fi)
NZ (1) NZ223236A (fi)
PH (1) PH26263A (fi)
PT (1) PT86600B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
JPH04503660A (ja) * 1988-12-05 1992-07-02 バイオジェン インコーポレイテッド 血小板凝集抑制の方法及び組成物
US5232912A (en) * 1988-12-07 1993-08-03 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
AU630132B2 (en) * 1988-12-07 1992-10-22 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
ZA907743B (en) * 1989-10-03 1991-07-31 Merrell Dow Pharma Radiolabeled anticoagulant peptides
CA2026376C (en) * 1989-10-03 2002-01-01 John L. Krstenansky Anticoagulant peptides
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
CA2035917C (en) * 1990-02-13 2001-10-02 John L. Krstenansky Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4005591A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Die blutgerinnung inhibierende peptide, verfahren zu ihrer herstellung und ihre verwendung
US6060451A (en) * 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
AU640502B2 (en) * 1990-07-24 1993-08-26 Merrell Dow Pharmaceuticals Inc. Analogs of hirudin having antiplatelet activity
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
CA2086243C (en) * 1990-07-24 2001-10-02 John L. Krstenansky Anticoagulant peptides
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
DE4103649A1 (de) * 1991-02-07 1992-08-13 Basf Ag Neue antikoagulatorisch wirksame peptide
US5767235A (en) * 1991-03-05 1998-06-16 Nippon Mining Company Limited Anticoagulant hirudin variants and methods for their production
ATE142642T1 (de) * 1991-03-05 1996-09-15 Japan Energy Corp Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz
IT1250689B (it) * 1991-07-22 1995-04-21 Marco Gerna Analoghi dell'irudina e procedimento per la loro preparazione
PT100757A (pt) * 1991-07-31 1993-10-29 Pasteur Institut Polipeptidos aptos para induzir "in vivo"anticorpos capazes de inibir a invasao de globulos vermelhos por merozoitos de "p.falciparum", produtos aparentados e sua aplicacao na producao de composicoes de vacinacao
EP0702696B1 (en) * 1993-06-11 2003-07-30 Merrell Pharmaceuticals Inc. Trifunctional antithrombin and antiplatelet peptides
GB9426038D0 (en) 1994-12-22 1995-02-22 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
US6057314A (en) * 1995-12-21 2000-05-02 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
US5831003A (en) * 1996-06-28 1998-11-03 Bayer Corporation Peptides which bind to prothrombin and thrombin
GB0209249D0 (en) * 2002-04-23 2002-06-05 Evolutec Ltd Anticoagulants
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
CN102757479B (zh) * 2012-05-09 2014-04-30 北京林业大学 高活性降血压肽及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.

Also Published As

Publication number Publication date
JPS63215698A (ja) 1988-09-08
AU1072988A (en) 1988-07-28
IE63547B1 (en) 1995-05-17
PT86600B (pt) 1991-12-31
DK173757B1 (da) 2001-09-10
FI880286A (fi) 1988-07-24
AU601801B2 (en) 1990-09-20
PT86600A (pt) 1988-02-01
PH26263A (en) 1992-04-01
DE3851238T2 (de) 1995-03-16
HU199159B (en) 1990-01-29
KR880009045A (ko) 1988-09-13
NO880268D0 (no) 1988-01-22
IL85159A (en) 1993-04-04
DK31088D0 (da) 1988-01-22
FI89060C (fi) 1993-08-10
NO174105B (no) 1993-12-06
NZ223236A (en) 1989-11-28
NO880268L (no) 1988-07-25
AR245140A1 (es) 1993-12-30
CN88100260A (zh) 1988-11-09
FI880286A0 (fi) 1988-01-22
IE880167L (en) 1988-07-23
HUT46339A (en) 1988-10-28
EP0276014A3 (en) 1990-05-16
NO174105C (no) 1994-03-16
DE3851238D1 (de) 1994-10-06
EP0276014B1 (en) 1994-08-31
CA1341032C (en) 2000-06-20
IL85159A0 (en) 1988-06-30
ATE110743T1 (de) 1994-09-15
KR960014105B1 (ko) 1996-10-14
DK31088A (da) 1988-07-24
EP0276014A2 (en) 1988-07-27
JP2709817B2 (ja) 1998-02-04
ES2063740T3 (es) 1995-01-16

Similar Documents

Publication Publication Date Title
FI89060B (fi) Foerfarnde foer framstaellning av terapeutiskt anvaendbara peptidderivat
PT86875A (pt) Process for the preparation of phenylcarbamate
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
LV10614A (lv) 2-anilinopirimidina atvasinajumi
PT87191A (pt) Process for the preparation of nucleosides
NO176922C (no) Fremgangsmåte for fremstilling av bifunksjonelle proteiner
FI883382A0 (fi) Anvaendning av olefinfoereningar.
NO176312C (no) Fremgangsmåte til opparbeidelse av kontaminerte mineralstoffer
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
NO175292C (no) Fluidseparator
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
FI86675C (fi) Foerfarande och anordning foer sammanfogning av profilstycken
PT87236A (pt) Process for the preparation of angiogenin inhibitors
DK373688D0 (da) Behandlingsmetode
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
PT87705A (pt) Process for the preparation of 6-deoxy guanine derivative
PT87593A (pt) Process for the preparation of nucleosides and of pharmaceutical compounds containing them
PT87732A (pt) Process for the preparation of (e)-(p-fluorophenethyl)-3-fluoroallylamine
BR8806292A (pt) Compositos de elevada integridade
FR2599038B1 (fr) Procede de preparation de nonacosapeptides et peptides intermediaires
FR2603887B1 (fr) Procede de preparation de l-tryptophane et de dl-serine
FI925209A (fi) Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliskt substituerade foereningar
FR2623497B1 (fr) Procede de preparation de perfluoroalcanecarboxamides
DK681288A (da) Aenootropt terapeutisk laegemiddelae

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.